NEWSLETTER SEPTEMBER 2020
Designing the framework for a new European paediatric research infrastructure
I am pleased to welcome you to the eighth newsletter of the EPTRI project.
As you know, EPTRI has just completed the design phase and tested both scientific concept and technical maturity and feasibility. It was a challenging and exciting pathway that we are happy to have carried out with you. Through the work done by the EPTRI partners, experts subgroups and stakeholders consultations, the four Thematic Research Platforms (Paediatric Medicines Discovery, Paediatric Biomarkers and Biosamples, Developmental Pharmacology, Paediatric Medicines Formulations) have been defined as corresponding to cutting edge science fields and related technologies and services and the Governance of the future RI has been designed.
Another important goal was achieved with the application to the ESFRI Roadmap 2021 successfully submitted on the 9th of September, with the support of 18 EU and non-EU Governments and 109 Institutions from 25 countries signing the EPTRI Memorandum of Understanding.
The inclusion of EPTRI in the Roadmap will be of great relevance as it will recognise EPTRI as a competitive infrastructure able to provide high-quality services to the paediatric community.
But EPTRI has not ended when the funding period is over! We have indeed started the Preparation phase and we are planning all the future steps that include the creation of the national nodes.
The preparatory phase (2020-2024) is expected to be funded by a new H2020 project, national funding and in-kind contribution from the Institutions signing the MoU. It will be mainly dedicated to preparing the legal, organisational, technical and economic framework to create the new RI. To this aim, all the documents will be prepared for the submission of the application to set up an ERIC and the Assembly with Member States Representatives will meet to reach a full consensus on it.
Stay tuned to the latest EPTRI news on Facebook, LinkedIn and You Tube.
We make science for everybody!
Mariangela Lupo Networking Manager
A new phase for the European Paediatric Translational Research Infrastructure: EPTRI-IA
Pharmaceuticals- safe and affordable medicines (new EU strategy)
EPTRI at the 12th Annual Conference EuPFI
Enpr-EMA comment to FDA docket on Rare Disease Clinical Trial Networks was submitted
In June 2020, The Food and Drug Administration launched a docket to require inputs and comments from patients, patient advocates, the scientific community, health professionals, regulatory and health authorities and general public regarding practical steps to establish a rare diseases clinical trial network.
The Lancet 2020 Campaign on child and adolescent health
The world’s leading independent general medical journal the Lancet started “The Lancet 2020 Campaign on child and adolescent health” with the aim to reiterate the centrality of child survival and wellbeing in global development.
Virtual meeting on “Precision Medicine in Paediatrics – Biotechnology and applications for development and health”
September 28th and 29th 2020, Online
The virtual meeting entitled “Precision Medicine in Paediatrics – Biotechnology and applications for development and health” will take place online on the 28th – 29th of September. The event has been organized by the institutes ITB and IRIB of the CNR (National Research Council), IRCCS (Scientific Institute for Research, Hospitalization and Healthcare) Medea and CVBF, in the framework of the European Biotech Week 2020.
Webinar on “Paediatric diseases: research, biodrugs and territory”
September 29th 2020, Online
On 29th September, in occasion of the 2020 Edition of the European Biotech Week, the Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM) of National Research Council (CNR) will organise the Webinar entitled “Paediatric Diseases: research, biodrugs and territory”. The online event intends to be a crossroad point for a diverse community of future researchers, working in different areas but united by the necessity to share experiences and knowledge in the field of Biotechnology.
EPTRI webinar: biotechnology to bring innovation in the paediatric drug development
October 2nd 2020, Online
EPTRI will organise the half-day webinar entitled “Biotechnology to bring innovation in the paediatric drug development” on 2nd of October, 2020, in occasion of the 2020 Edition of the European Biotech Week The webinar will provide the opportunity to discuss and raise awareness on the serious lack of medicines for children in EU and worldwide and to promote the application of biotechnology to bring innovation in the paediatric drug discovery and early development phases.
EPTRI at the EAPS meeting 2020
October 16-19th 2020, Online
The 8th Congress of the European Academy of Paediatric Societies (EAPS 2020) will be held virtually on the 16th- 19th of October, 2020. The Congress is organised by three societies: the European Academy of Paediatrics (EAP), the European Society for Paediatric Research (ESPR) and the European Society of Paediatric and Neonatal Intensive Care (ESPNIC) with the eleven other European paediatric societies joining as collaborating societies.
EPTRI at the XIII Foresight Training Course “Challenges for Researchers and Regulators facing the pandemic crisis” – 23 October 2020 (virtual event) Technologies for Life Sciences 2021
October 23th 2020, Online
Fondazione Gianni Benzi will organize the XIII Foresight Training Course (FTC) – “Challenges for Researchers and Regulators facing the pandemic crisis” that will run virtually on 23 October 2020 at 09:30 AM (CEST) and will be focused on how the pandemic crisis forced the European Pharmaceutical System to change.
EPTRI at the Europe Biobank Week 2020
November 17th-20th 2020, Online
Europe Biobank Week 2020, the largest biobanking conference in Europe, will take place between 17-20 November in a virtual format for the first time. The conference is a joint effort of ESBB and BBMRI-ERIC. This year’s edition will roll out completely online, creating new opportunities to attend sessions and fully enjoy all the great scientific insights from speakers and panelists. EPTRI has submitted two abstracts in the event.
EVENTS OF INTEREST
October 21th and 22th 2020, Online
The Food and Drug Administration (FDA) in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) will host a two-day virtual public workshop entitled “Pediatric Dose Selection” on October 22nd and 23rd, 2020 to discuss the present state of dose selection and how it pertains to paediatric drug development.